메뉴 건너뛰기




Volumn 58, Issue 1, 2013, Pages 184-189

Vitamin D for your patients with chronic hepatitis C?

Author keywords

Hepatitis C; Vitamin D

Indexed keywords

ANTIFIBROTIC AGENT; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; COLECALCIFEROL; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; RIBAVIRIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

EID: 84871189038     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.07.026     Document Type: Note
Times cited : (42)

References (46)
  • 5
    • 84855842625 scopus 로고    scopus 로고
    • Increasing requests for vitamin D measurement: Costly, confusing, and without credibility
    • N. Sattar, P. Welsh, M. Panarelli, and N.G. Forouhi Increasing requests for vitamin D measurement: costly, confusing, and without credibility Lancet 379 2012 95 96
    • (2012) Lancet , vol.379 , pp. 95-96
    • Sattar, N.1    Welsh, P.2    Panarelli, M.3    Forouhi, N.G.4
  • 7
    • 84455189495 scopus 로고    scopus 로고
    • Classical and emerging roles of vitamin D in hepatitis C virus infection
    • J.A. Gutierrez, N. Parikh, and A.D. Branch Classical and emerging roles of vitamin D in hepatitis C virus infection Semin Liver Dis 31 2011 387 398
    • (2011) Semin Liver Dis , vol.31 , pp. 387-398
    • Gutierrez, J.A.1    Parikh, N.2    Branch, A.D.3
  • 8
    • 0242624558 scopus 로고    scopus 로고
    • Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: Not just a cholestatic problem
    • E.J. Carey, V. Balan, W.K. Kremers, and J.E. Hay Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem Liver Transpl 9 2003 1166 1173
    • (2003) Liver Transpl , vol.9 , pp. 1166-1173
    • Carey, E.J.1    Balan, V.2    Kremers, W.K.3    Hay, J.E.4
  • 9
    • 67149139614 scopus 로고    scopus 로고
    • Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults
    • F. Collin, X. Duval, V. Le Moing, L. Piroth, F. Al Kaied, and P. Massip Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults AIDS 23 2009 1021 1024
    • (2009) AIDS , vol.23 , pp. 1021-1024
    • Collin, F.1    Duval, X.2    Le Moing, V.3    Piroth, L.4    Al Kaied, F.5    Massip, P.6
  • 10
    • 75449098534 scopus 로고    scopus 로고
    • Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus
    • Y. Arase, F. Suzuki, Y. Suzuki, N. Akuta, M. Kobayashi, and H. Sezaki Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus J Med Virol 82 2010 390 395
    • (2010) J Med Virol , vol.82 , pp. 390-395
    • Arase, Y.1    Suzuki, F.2    Suzuki, Y.3    Akuta, N.4    Kobayashi, M.5    Sezaki, H.6
  • 15
    • 84866382064 scopus 로고    scopus 로고
    • D-livering the message: The importance of vitamin D status in chronic liver disease
    • M.T. Kitson, and S.K. Roberts D-livering the message: the importance of vitamin D status in chronic liver disease J Hepatol 57 2012 897 909
    • (2012) J Hepatol , vol.57 , pp. 897-909
    • Kitson, M.T.1    Roberts, S.K.2
  • 16
    • 77950624679 scopus 로고    scopus 로고
    • Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C
    • S. Petta, C. Cammà, C. Scazzone, C. Tripodo, V. Di Marco, and A. Bono Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C Hepatology 51 2010 1158 1167
    • (2010) Hepatology , vol.51 , pp. 1158-1167
    • Petta, S.1    Cammà, C.2    Scazzone, C.3    Tripodo, C.4    Di Marco, V.5    Bono, A.6
  • 17
    • 84863524541 scopus 로고    scopus 로고
    • Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner
    • P.J. Clark, A.J. Thompson, D.M. Vock, L.E. Kratz, A.A. Tolun, and A.J. Muir Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner Hepatology 56 2012 49 56
    • (2012) Hepatology , vol.56 , pp. 49-56
    • Clark, P.J.1    Thompson, A.J.2    Vock, D.M.3    Kratz, L.E.4    Tolun, A.A.5    Muir, A.J.6
  • 18
    • 84858281844 scopus 로고    scopus 로고
    • Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients
    • K. Baur, J.C. Mertens, J. Schmitt, R. Iwata, B. Stieger, and J.J. Eloranta Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients Liver Int 32 2012 635 643
    • (2012) Liver Int , vol.32 , pp. 635-643
    • Baur, K.1    Mertens, J.C.2    Schmitt, J.3    Iwata, R.4    Stieger, B.5    Eloranta, J.J.6
  • 19
    • 0032939394 scopus 로고    scopus 로고
    • Soluble tumor necrosis factor receptors in chronic hepatitis C: A correlation with histological fibrosis and activity
    • H. Zylberberg, A.C. Rimaniol, S. Pol, A. Masson, D. De Groote, and P. Berthelot Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity J Hepatol 30 1999 185 191
    • (1999) J Hepatol , vol.30 , pp. 185-191
    • Zylberberg, H.1    Rimaniol, A.C.2    Pol, S.3    Masson, A.4    De Groote, D.5    Berthelot, P.6
  • 20
    • 0033135531 scopus 로고    scopus 로고
    • Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection
    • Y. Itoh, T. Okanoue, N. Ohnishi, M. Sakamoto, K. Nishioji, and Y. Nakagawa Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection Am J Gastroenterol 94 1999 1332 1340
    • (1999) Am J Gastroenterol , vol.94 , pp. 1332-1340
    • Itoh, Y.1    Okanoue, T.2    Ohnishi, N.3    Sakamoto, M.4    Nishioji, K.5    Nakagawa, Y.6
  • 21
    • 12444303314 scopus 로고    scopus 로고
    • TNF-{alpha}, chronic hepatitis C and diabetes: A novel triad
    • H. Knobler, and A. Schattner TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad QJM 98 2005 1 6
    • (2005) QJM , vol.98 , pp. 1-6
    • Knobler, H.1    Schattner, A.2
  • 22
    • 81555210113 scopus 로고    scopus 로고
    • Hepatic TLR2 & TLR4 expression correlates with hepatic inflammation and TNF-α in HCV & HCV/HIV infection
    • M.D. Berzsenyi, S.K. Roberts, S. Preiss, D.J. Woollard, M.R. Beard, and N.A. Skinner Hepatic TLR2 & TLR4 expression correlates with hepatic inflammation and TNF-α in HCV & HCV/HIV infection J Viral Hepat 18 2011 852 860
    • (2011) J Viral Hepat , vol.18 , pp. 852-860
    • Berzsenyi, M.D.1    Roberts, S.K.2    Preiss, S.3    Woollard, D.J.4    Beard, M.R.5    Skinner, N.A.6
  • 23
    • 33748511848 scopus 로고    scopus 로고
    • Toll-like receptor expression in chronic hepatitis C: Correlation with pro-inflammatory cytokine levels and liver injury
    • S. Riordan, N. Skinner, J. Kurtovic, S. Locarnini, C. McIver, and R. Williams Toll-like receptor expression in chronic hepatitis C: correlation with pro-inflammatory cytokine levels and liver injury Inflamm Res 55 2006 279 285
    • (2006) Inflamm Res , vol.55 , pp. 279-285
    • Riordan, S.1    Skinner, N.2    Kurtovic, J.3    Locarnini, S.4    McIver, C.5    Williams, R.6
  • 24
    • 34250354423 scopus 로고    scopus 로고
    • Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology
    • T.I. Ng, H. Mo, T. Pilot-Matias, Y. He, G. Koev, and P. Krishnan Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology Hepatology 45 2007 1413 1421
    • (2007) Hepatology , vol.45 , pp. 1413-1421
    • Ng, T.I.1    Mo, H.2    Pilot-Matias, T.3    He, Y.4    Koev, G.5    Krishnan, P.6
  • 25
    • 13844294333 scopus 로고    scopus 로고
    • Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: A phase 2 randomized, double-blind, placebo-controlled study
    • N.N. Zein Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study J Hepatol 42 2005 315 322
    • (2005) J Hepatol , vol.42 , pp. 315-322
    • Zein, N.N.1
  • 26
    • 63449102214 scopus 로고    scopus 로고
    • Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection
    • J.R. Larrubia, S. Benito-Martínez, M. Calvino, E. Sanz-de-Villalobos, and T. Parra-Cid Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection World J Gastroenterol 14 2008 7149 7159
    • (2008) World J Gastroenterol , vol.14 , pp. 7149-7159
    • Larrubia, J.R.1    Benito-Martínez, S.2    Calvino, M.3    Sanz-De-Villalobos, E.4    Parra-Cid, T.5
  • 27
    • 78650962504 scopus 로고    scopus 로고
    • Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
    • A. Casrouge, J. Decalf, M. Ahloulay, C. Lababidi, H. Mansour, and A. Vallet-Pichard Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV J Clin Invest 121 2011 308 317
    • (2011) J Clin Invest , vol.121 , pp. 308-317
    • Casrouge, A.1    Decalf, J.2    Ahloulay, M.3    Lababidi, C.4    Mansour, H.5    Vallet-Pichard, A.6
  • 28
    • 60649109332 scopus 로고    scopus 로고
    • 1Alpha, 25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes
    • C. Almerighi, A. Sinistro, A. Cavazza, C. Ciaprini, G. Rocchi, and A. Bergamini 1Alpha, 25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes Cytokine 45 2009 190 197
    • (2009) Cytokine , vol.45 , pp. 190-197
    • Almerighi, C.1    Sinistro, A.2    Cavazza, A.3    Ciaprini, C.4    Rocchi, G.5    Bergamini, A.6
  • 29
    • 77955834746 scopus 로고    scopus 로고
    • Effects of vitamin D3 on expression of tumor necrosis factor-α and chemokines by monocytes
    • Y. Kuo, C. Kuo, K. Lam, Y. Chu, W. Wang, and C. Huang Effects of vitamin D3 on expression of tumor necrosis factor-α and chemokines by monocytes J Food Sci 75 2010 H200 H204
    • (2010) J Food Sci , vol.75
    • Kuo, Y.1    Kuo, C.2    Lam, K.3    Chu, Y.4    Wang, W.5    Huang, C.6
  • 30
    • 32944464959 scopus 로고    scopus 로고
    • Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns
    • K. Sadeghi, B. Wessner, U. Laggner, M. Ploder, D. Tamandl, and J. Friedl Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns Eur J Immunol 36 2006 361 370
    • (2006) Eur J Immunol , vol.36 , pp. 361-370
    • Sadeghi, K.1    Wessner, B.2    Laggner, U.3    Ploder, M.4    Tamandl, D.5    Friedl, J.6
  • 31
    • 33845949937 scopus 로고    scopus 로고
    • 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic Cells
    • G. Penna, S. Amuchastegui, N. Giarratana, K.C. Daniel, M. Vulcano, and S. Sozzani 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic Cells J Immunol 178 2007 145 153
    • (2007) J Immunol , vol.178 , pp. 145-153
    • Penna, G.1    Amuchastegui, S.2    Giarratana, N.3    Daniel, K.C.4    Vulcano, M.5    Sozzani, S.6
  • 32
    • 44849107073 scopus 로고    scopus 로고
    • Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behçet's disease
    • J.E. Do, S.Y. Kwon, S. Park, and E.-S. Lee Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behçet's disease Rheumatology 47 2008 840 848
    • (2008) Rheumatology , vol.47 , pp. 840-848
    • Do, J.E.1    Kwon, S.Y.2    Park, S.3    Lee, E.-S.4
  • 34
    • 84871201103 scopus 로고    scopus 로고
    • 25-hydroxyvitamin D3 conversion by dendritic cells and T cells drives 1,25-dihydroxyvitamin D3 mediated anti-inflammatory CD4+ T cell responses
    • L. Jeffery, K. Raza, A. Filer, and D. Sansom 25-hydroxyvitamin D3 conversion by dendritic cells and T cells drives 1,25-dihydroxyvitamin D3 mediated anti-inflammatory CD4+ T cell responses Ann Rheum Dis 70 2011 A45
    • (2011) Ann Rheum Dis , vol.70 , pp. 45
    • Jeffery, L.1    Raza, K.2    Filer, A.3    Sansom, D.4
  • 35
    • 1842479859 scopus 로고    scopus 로고
    • Diagnosis, management, and treatment of hepatitis C
    • D.B. Strader, T. Wright, D.L. Thomas, and L.B. Seeff Diagnosis, management, and treatment of hepatitis C Hepatology 39 2004 1147 1171
    • (2004) Hepatology , vol.39 , pp. 1147-1171
    • Strader, D.B.1    Wright, T.2    Thomas, D.L.3    Seeff, L.B.4
  • 36
    • 80655127773 scopus 로고    scopus 로고
    • Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats
    • S. Abramovitch, L. Dahan-Bachar, E. Sharvit, Y. Weisman, A. Ben Tov, and E. Brazowski Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats Gut 60 2011 1728 1737
    • (2011) Gut , vol.60 , pp. 1728-1737
    • Abramovitch, S.1    Dahan-Bachar, L.2    Sharvit, E.3    Weisman, Y.4    Ben Tov, A.5    Brazowski, E.6
  • 37
    • 33845242306 scopus 로고    scopus 로고
    • Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy
    • X. Tan, Y. Li, and Y. Liu Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy J Am Soc Nephrol 17 2006 3382 3393
    • (2006) J Am Soc Nephrol , vol.17 , pp. 3382-3393
    • Tan, X.1    Li, Y.2    Liu, Y.3
  • 38
    • 33645224419 scopus 로고    scopus 로고
    • Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response
    • P.T. Liu, S. Stenger, H. Li, L. Wenzel, B.H. Tan, and S.R. Krutzik Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response Science 311 2006 1770 1773
    • (2006) Science , vol.311 , pp. 1770-1773
    • Liu, P.T.1    Stenger, S.2    Li, H.3    Wenzel, L.4    Tan, B.H.5    Krutzik, S.R.6
  • 39
    • 80055060055 scopus 로고    scopus 로고
    • Vitamin D: An innate antiviral agent suppressing hepatitis C virus in human hepatocytes
    • M. Gal-Tanamy, L. Bachmetov, A. Ravid, R. Koren, A. Erman, and R. Tur-Kaspa Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes Hepatology 54 2011 1570 1579
    • (2011) Hepatology , vol.54 , pp. 1570-1579
    • Gal-Tanamy, M.1    Bachmetov, L.2    Ravid, A.3    Koren, R.4    Erman, A.5    Tur-Kaspa, R.6
  • 41
    • 84861664707 scopus 로고    scopus 로고
    • The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients
    • K. Baur, J.C. Mertens, J. Schmitt, R. Iwata, B. Stieger, and P. Frei The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients Antivir Ther 17 2012 541 547
    • (2012) Antivir Ther , vol.17 , pp. 541-547
    • Baur, K.1    Mertens, J.C.2    Schmitt, J.3    Iwata, R.4    Stieger, B.5    Frei, P.6
  • 42
    • 84868193472 scopus 로고    scopus 로고
    • Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C
    • [Epub ahead of print]
    • E. Falleti, D. Bitetto, C. Fabris, G. Fattovich, A. Cussigh, and S. Cmet Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C Hepatology 2012 [Epub ahead of print]
    • (2012) Hepatology
    • Falleti, E.1    Bitetto, D.2    Fabris, C.3    Fattovich, G.4    Cussigh, A.5    Cmet, S.6
  • 43
    • 78650008697 scopus 로고    scopus 로고
    • Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C
    • D. Bitetto, C. Fabris, E. Fornasiere, C. Pipan, E. Fumolo, and A. Cussigh Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C Transpl Int 24 2011 43 50
    • (2011) Transpl Int , vol.24 , pp. 43-50
    • Bitetto, D.1    Fabris, C.2    Fornasiere, E.3    Pipan, C.4    Fumolo, E.5    Cussigh, A.6
  • 44
    • 83755196636 scopus 로고    scopus 로고
    • Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients
    • S. Abu-Mouch, Z. Fireman, J. Jarchovsky, A.-R. Zeina, and N. Assy Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients World J Gastroenterol 17 2011 5184 5190
    • (2011) World J Gastroenterol , vol.17 , pp. 5184-5190
    • Abu-Mouch, S.1    Fireman, Z.2    Jarchovsky, J.3    Zeina, A.-R.4    Assy, N.5
  • 45
    • 84857532001 scopus 로고    scopus 로고
    • Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients
    • A. Nimer, and A. Mouch Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients World J Gastroenterol 18 2012 800 805
    • (2012) World J Gastroenterol , vol.18 , pp. 800-805
    • Nimer, A.1    Mouch, A.2
  • 46
    • 77951961788 scopus 로고    scopus 로고
    • Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren
    • M. Urashima, T. Segawa, M. Okazaki, M. Kurihara, Y. Wada, and H. Ida Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren Am J Clin Nutr 91 2010 1255 1260
    • (2010) Am J Clin Nutr , vol.91 , pp. 1255-1260
    • Urashima, M.1    Segawa, T.2    Okazaki, M.3    Kurihara, M.4    Wada, Y.5    Ida, H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.